HPLC‐FLD determination of NBD‐cholesterol,its ester and other metabolites in cellular lipid extracts

22‐N(?7‐Nitrobenz‐2‐oxa‐1,3‐diazol‐4‐yl)amino]‐23,24‐bisnor‐5‐cholen‐3β‐ol (NBD‐cholesterol), a fluorescent cholesterol analog, was an extragenous cholesterol tracer used to study cholesterol absorption and metabolism in cultured cells. In order to measure free intracellular cholesterol and its esters, a precise and sensitive method employing high‐performance liquid chromatography/fluorescence detection (HPLC‐FLD) was developed for the first time. Method validation showed a limit of detection at 30 ng/mL. The calibration curve was linear within the range of 0.0625–10.0 µg/mL (r² = 0.999). Accuracy and precision were highlighted by good recovery and low variations. Apart from NBD‐cholesteryl oleate, two additional cellular metabolites of NBD‐cholesterol, probably an isomer and an oxidation product, were determined in the lipid extracts of Caco‐2 human colon adenocarcinoma cells according to mass spectrometry. In AC29 mouse malignant mesothelioma cells overexpressing acyl‐CoA:cholesterol acyltransferase‐1 (ACAT1) or ACAT2, only the oxidized metabolite was detected. Using the newly developed method, YIC‐C8‐434, a known ACAT inhibitor, was shown to inhibit ACAT activity in Caco‐2 cells, as well as in AC29/ACAT1 or AC29/ACAT2 cells. In conclusion, the sensitive and specific HPLC‐FLD method is a powerful tool for simultaneous quantification of intracellular NBD‐cholesterol and its oleoyl‐ester. Copyright © 2013 John Wiley & Sons, Ltd.